Participant guide
How studies are reviewed and monitored
Every Alzheimer's disease study has to be reviewed by an independent committee before it can enroll you or the person you care for. That review keeps going for as long as the study runs.
Updated
Independent review
The committee is called an Institutional Review Board, or IRB, and it is independent of the researchers. Before a study can start, the IRB goes through the study plan and the consent document. It does not stop there. The review carries on while the study is under way, and the whole purpose is to protect the rights and welfare of participants, whether that is you or a family member.
Who runs Alzheimer's disease studies
As of November 16, 2026, 288 Alzheimer's disease studies are recruiting participants in the United States, according to ClinicalTrials.gov. By sponsor: university, hospital or other (209), industry (70), government (9). The sponsor is the organization responsible for a study.
See which Alzheimer's disease studies are recruiting near you.
Federal rules
Alzheimer's disease studies in the United States must follow federal regulations. Those rules spell out how you, or someone you care for, must be informed and protected. The U.S. Food and Drug Administration also oversees medication and device studies.
Monitoring during the study
During a study, the team checks on your health at scheduled visits and writes down any problems you tell them about. Nothing is locked in place, either. A study can be changed, paused, or stopped if a serious concern comes up.
All of this oversight lowers risk. It does not take risk away. Whether you are thinking about taking part yourself or reading for someone you care for, it helps to know that every study carries risks, and that the known ones are described in the consent document.
Talk with a study coordinator
To hear which Alzheimer's disease studies may fit and what the next step looks like, call (888) 927-5895 or send a short form and a coordinator will talk it through with you. Whether you are asking for yourself or for a family member, a question never commits you to anything.
Sources and further reading
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Regulations to Protect Research Participants — HHS Office for Human Research Protections
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services